Wendell David Associates Inc Johnson & Johnson Transaction History

Wendell David Associates Inc

$1.05 Billion
Q3 2024

A detailed history of Wendell David Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Wendell David Associates Inc holds 112,330 shares of JNJ stock, worth $16.4 Million. This represents 1.74% of its overall portfolio holdings.

Number of Shares

112,330

Previous 114,259 1.69%

Holding current value

$16.4 Million

Previous $16.7 Million 9.01%

% of portfolio

1.74%

Previous 1.7%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$145.48 - $167.38 $280,630 - $322,876	-1,929 Reduced 1.69%	112,330 $18.2 Million
Q2 2024 Jul 22, 2024	BUY	$144.38 - $157.78 $10,828 - $11,833	75 Added 0.07%	114,259 $16.7 Million
Q1 2024 Apr 22, 2024	SELL	$155.22 - $162.74 $55,568 - $58,260	-358 Reduced 0.31%	114,184 $18.1 Million
Q4 2023 Jan 22, 2024	SELL	$145.6 - $158.88 $82,992 - $90,561	-570 Reduced 0.5%	114,542 $18 Million
Q3 2023 Oct 20, 2023	BUY	$155.75 - $174.48 $979,667 - $1.1 Million	6,290 Added 5.78%	115,112 $17.9 Million
Q2 2023 Jul 20, 2023	SELL	$154.35 - $166.11 $13,891 - $14,949	-90 Reduced 0.08%	108,822 $18 Million
Q1 2023 Apr 19, 2023	BUY	$151.05 - $180.26 $98,182 - $117,169	650 Added 0.6%	108,912 $16.9 Million
Q4 2022 Jan 17, 2023	SELL	$160.2 - $179.79 $88,110 - $98,884	-550 Reduced 0.51%	108,262 $19.1 Million
Q3 2022 Oct 18, 2022	SELL	$161.33 - $179.52 $21,779 - $24,235	-135 Reduced 0.12%	108,812 $17.8 Million
Q2 2022 Jul 14, 2022	SELL	$168.19 - $186.01 $42,047 - $46,502	-250 Reduced 0.23%	108,947 $19.3 Million
Q1 2022 Apr 22, 2022	SELL	$158.14 - $179.59 $139,163 - $158,039	-880 Reduced 0.8%	109,197 $19.4 Million
Q4 2021 Jan 24, 2022	SELL	$155.93 - $173.01 $15,748 - $17,474	-101 Reduced 0.09%	110,077 $18.8 Million
Q3 2021 Oct 19, 2021	BUY	$161.5 - $179.47 $46,027 - $51,148	285 Added 0.26%	110,178 $17.8 Million
Q2 2021 Jul 19, 2021	BUY	$159.48 - $171.07 $168,410 - $180,649	1,056 Added 0.97%	109,893 $18.1 Million
Q1 2021 Apr 20, 2021	BUY	$153.07 - $170.48 $45,461 - $50,632	297 Added 0.27%	108,837 $17.9 Million
Q4 2020 Jan 22, 2021	SELL	$137.11 - $157.38 $143,554 - $164,776	-1,047 Reduced 0.96%	108,540 $17.1 Million
Q3 2020 Oct 20, 2020	SELL	$140.38 - $153.83 $379,026 - $415,341	-2,700 Reduced 2.4%	109,587 $16.3 Million
Q2 2020 Jul 17, 2020	SELL	$128.81 - $155.51 $236,108 - $285,049	-1,833 Reduced 1.61%	112,287 $15.8 Million
Q1 2020 Apr 16, 2020	SELL	$111.14 - $153.99 $59,682 - $82,692	-537 Reduced 0.47%	114,120 $15 Million
Q4 2019 Jan 17, 2020	SELL	$127.5 - $146.44 $371,025 - $426,140	-2,910 Reduced 2.48%	114,657 $16.7 Million
Q3 2019 Oct 22, 2019	BUY	$126.95 - $142.14 $48,494 - $54,297	382 Added 0.33%	117,567 $15.2 Million
Q2 2019 Jul 16, 2019	SELL	$131.15 - $144.24 $135,740 - $149,288	-1,035 Reduced 0.88%	117,185 $16.3 Million
Q1 2019 Apr 11, 2019	SELL	$125.72 - $139.79 $72,163 - $80,239	-574 Reduced 0.48%	118,220 $16.5 Million
Q4 2018 Jan 17, 2019	SELL	$122.84 - $147.84 $87,339 - $105,114	-711 Reduced 0.59%	118,794 $15.3 Million
Q3 2018 Oct 12, 2018	BUY	$121.58 - $142.88 $268,691 - $315,764	2,210 Added 1.88%	119,505 $16.5 Million
Q2 2018 Jul 16, 2018	BUY	$119.4 - $131.76 $487,868 - $538,371	4,086 Added 3.61%	117,295 $14.2 Million
Q1 2018 Apr 11, 2018	BUY	$125.1 - $148.14 $136,984 - $162,213	1,095 Added 0.98%	113,209 $14.5 Million
Q4 2017 Jan 16, 2018	SELL	$131.22 - $143.62 $574,087 - $628,337	-4,375 Reduced 3.76%	112,114 $15.7 Million
Q3 2017 Oct 17, 2017	BUY	$129.47 - $135.38 $15.1 Million - $15.8 Million	116,489	116,489 $15.1 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Account

Wendell David Associates Inc Johnson & Johnson Transaction History